Torrent Pharmaceuticals Ltd vs Rekvina Labs Ltd

A side-by-side comparison of Torrent Pharmaceuticals Ltd (TORNTPHARM) and Rekvina Labs Ltd (VINRKLB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Torrent Pharmaceuticals Ltd leads TORNTPHARM vs VINRKLB on 7 of 14 metrics (2 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

78.86
P/E ratio
0.00
20.18
P/B ratio
-14.47
0.76%
Dividend yield
0.00%
₹63.92
EPS
₹-0.12

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

27.40%
Return on equity
41.27%
15.00%
Return on capital
41.27%
33.00%
EBITDA margin
0.00%
15.29%
Net margin
0.00%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

13.27%
Revenue CAGR (3Y)
19.75%
Profit CAGR (3Y)

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.84L Cr
Market cap
₹18 Cr
₹13,980 Cr
Revenue
₹0 Cr
₹2,138 Cr
Net profit
₹-0 Cr
1.79
Debt / equity
0.00
Torrent Pharmaceuticals Ltd
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]
  • ["Stock is trading at 19.2 times its book value", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]
Rekvina Labs Ltd
  • ["Company has low interest coverage ratio."]
Torrent Pharmaceuticals Ltd full analysis Rekvina Labs Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.